Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher F D Li Wai Suen

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Alimentary Pharmacology & Therapeutics|May 24, 2020
Letter: how can we reduce mortality in elderly patients with acute severe ulcerative colitis?Christopher F D Li Wai Suen, Matthew C Choy, Peter De Cruz
Alimentary Pharmacology & Therapeutics|February 27, 2020
Letter: infliximab induction regimens in steroid-refractory acute severe colitis-a propensity score analysisChristopher F D Li Wai Suen, Matthew C Choy, Peter De Cruz
BMJ Case Reports|September 28, 2013
Acute liver injury secondary to sertralineChristopher F D Li Wai Suen, Ray Boyapati, Ian Simpson, et al.
Intestinal Research|May 15, 2024
What to do when traditional rescue therapies fail in acute severe ulcerative colitisChristopher F D Li Wai Suen, Matthew C Choy, Peter De Cruz
Internal Medicine Journal|September 6, 2024
Concomitant management of alopecia universalis and ulcerative colitis with upadacitinibTsz Hong Yiu, Elizabeth Chow, Claire Grills, et al.
Inflammatory Bowel Diseases|February 26, 2020
Letter to the Editor: Antibiotic Cocktail for Pediatric Acute Severe Colitis and the Microbiome: The PRASCO Randomized Controlled TrialRobert Gilmore, Matthew C Choy, Christopher F D Li Wai Suen, et al.
The Lancet. Gastroenterology & Hepatology|December 14, 2024
Intensified infliximab induction therapy for steroid-refractory acute severe ulcerative colitis - Authors' replyChristopher F D Li Wai Suen, Matthew C Choy, Danny Con, et al.
Gastroenterology|April 30, 2026
Reply to TakefujiChristopher F D Li Wai Suen, Danny Con, Matthew C Choy, et al.
The Lancet. Gastroenterology & Hepatology|February 15, 2025
Vedolizumab for prevention of recurrence of Crohn's diseaseAndrew Nguyen, Christopher F D Li Wai Suen, Ashish Srinivasan, et al.
Gastroenterology|February 25, 2026
Reply to Bourgonje and MianChristopher F D Li Wai Suen, Danny Con, Matthew C Choy, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Alimentary Pharmacology & Therapeutics|May 24, 2020
Letter: how can we reduce mortality in elderly patients with acute severe ulcerative colitis?Christopher F D Li Wai Suen, Matthew C Choy, Peter De Cruz
Alimentary Pharmacology & Therapeutics|February 27, 2020
Letter: infliximab induction regimens in steroid-refractory acute severe colitis-a propensity score analysisChristopher F D Li Wai Suen, Matthew C Choy, Peter De Cruz
BMJ Case Reports|September 28, 2013
Acute liver injury secondary to sertralineChristopher F D Li Wai Suen, Ray Boyapati, Ian Simpson, et al.
Intestinal Research|May 15, 2024
What to do when traditional rescue therapies fail in acute severe ulcerative colitisChristopher F D Li Wai Suen, Matthew C Choy, Peter De Cruz
Internal Medicine Journal|September 6, 2024
Concomitant management of alopecia universalis and ulcerative colitis with upadacitinibTsz Hong Yiu, Elizabeth Chow, Claire Grills, et al.
Inflammatory Bowel Diseases|February 26, 2020
Letter to the Editor: Antibiotic Cocktail for Pediatric Acute Severe Colitis and the Microbiome: The PRASCO Randomized Controlled TrialRobert Gilmore, Matthew C Choy, Christopher F D Li Wai Suen, et al.
The Lancet. Gastroenterology & Hepatology|December 14, 2024
Intensified infliximab induction therapy for steroid-refractory acute severe ulcerative colitis - Authors' replyChristopher F D Li Wai Suen, Matthew C Choy, Danny Con, et al.
Gastroenterology|April 30, 2026
Reply to TakefujiChristopher F D Li Wai Suen, Danny Con, Matthew C Choy, et al.
The Lancet. Gastroenterology & Hepatology|February 15, 2025
Vedolizumab for prevention of recurrence of Crohn's diseaseAndrew Nguyen, Christopher F D Li Wai Suen, Ashish Srinivasan, et al.
Gastroenterology|February 25, 2026
Reply to Bourgonje and MianChristopher F D Li Wai Suen, Danny Con, Matthew C Choy, et al.
Pageof 3